Sailaja Puttagunta - Dec 1, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Medical Officer
Signature
/s/ Sailaja Puttagunta
Stock symbol
ITRM
Transactions as of
Dec 1, 2022
Transactions value $
-$4,442
Form type
4
Date filed
12/5/2022, 04:00 PM
Previous filing
Dec 14, 2021
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Award $0 +8.33K $0.00 8.33K Dec 1, 2022 Direct F1, F2
transaction ITRM Ordinary Shares Sale -$4.44K -3.37K -40.38% $1.32 4.97K Dec 2, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -8.33K -25% $0.00 25K Dec 1, 2022 Ordinary Shares 8.33K Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 17, 2022, the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split
F2 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F3 Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
F4 The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
F5 On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022.